1. Assmann B, Göhlich G, Baethmann M et al (2006) Clinical findings and a therapeutic trial in the first patient with beta-ureidopropionase deficiency. Neuropediatrics 37:20–25
2. Becker MA (2001) Hyperuricemia and gout. In: Scriver CR, Beaudet al, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York
3. Becker MA (2011) Treatment of the hyperuricemia of gout in the United States. In: Book of abstracts of 14th international symposium on purine and pyrimidine metabolism in man, p. 51, February 12–21, 2011, Tokyo, Japan. Medical Toyou Co., Ltd, Tokyo
4. Bierau J (2010) ERNDIM Advisory Document of the quantitative analysis of purines and pyrimidines.
http://www.erndim.unibas.ch/pdf/PurPyr%20Guidance.pdf
. Accessed 16 Sept 2011
5. Bierau J, Lindhout M, Bakker JA (2007) Pharmacogenetic significance of inosine triphosphatase. Pharmacogenomics 8:1221–1228